• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫代苯并二氮杂卓作为 p53-MDM2 蛋白-蛋白相互作用抑制剂的构效关系和抗肿瘤活性。

Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors.

机构信息

School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, People's Republic of China.

出版信息

Eur J Med Chem. 2012 Oct;56:10-6. doi: 10.1016/j.ejmech.2012.08.003. Epub 2012 Aug 10.

DOI:10.1016/j.ejmech.2012.08.003
PMID:22940704
Abstract

In order to discuss the structure-activity relationship (SAR) of the thio-benzodiazepine compounds which showed excellent activity against p53-MDM2 protein-protein interaction, we designed and synthesized twenty compounds with electrophilic and nucleophilic groups on the benzene ring. Among them, compounds 8i (K(i) = 91 nM) and 8n (K(i) = 89 nM) showed better binding activity than that of the reference drug Nutlin-3a (K(i) = 121 nM). In addition, in vitro antitumor activity against Saos-2, U-2 OS, A549 and NCI-H1299 cell-lines were assayed by the MTT method. Especially, compounds 8i and 8n possessed excellent biological activity and good selectivity comparable to Nutlin-3a, which were promising candidates for further evaluation.

摘要

为了探讨对 p53-MDM2 蛋白-蛋白相互作用具有优异活性的硫苯并二氮杂䓬化合物的构效关系 (SAR),我们设计并合成了二十种在苯环上具有亲电和亲核基团的化合物。其中,化合物 8i(K(i) = 91 nM)和 8n(K(i) = 89 nM)与参比药物 Nutlin-3a(K(i) = 121 nM)相比表现出更好的结合活性。此外,通过 MTT 法测定了对 Saos-2、U-2 OS、A549 和 NCI-H1299 细胞系的体外抗肿瘤活性。特别是化合物 8i 和 8n 具有与 Nutlin-3a 相当的优异的生物活性和良好的选择性,是进一步评价的有希望的候选药物。

相似文献

1
Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors.硫代苯并二氮杂卓作为 p53-MDM2 蛋白-蛋白相互作用抑制剂的构效关系和抗肿瘤活性。
Eur J Med Chem. 2012 Oct;56:10-6. doi: 10.1016/j.ejmech.2012.08.003. Epub 2012 Aug 10.
2
Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction.硫代苯并二氮杂䓬类化合物的合成与生物评价作为新型小分子 p53-MDM2 蛋白-蛋白相互作用抑制剂。
Eur J Med Chem. 2011 Nov;46(11):5654-61. doi: 10.1016/j.ejmech.2011.09.043. Epub 2011 Oct 2.
3
Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 1.新型 3,4,5-三取代氨基噻吩类化合物的设计、合成及对 p53-MDM2 相互作用的抑制活性评价。第 1 部分。
Bioorg Med Chem. 2013 Jun 1;21(11):2879-85. doi: 10.1016/j.bmc.2013.03.061. Epub 2013 Apr 2.
4
Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 2.新型 3,4,5-三取代氨基噻吩类 p53-MDM2 相互作用抑制剂的设计、合成与生物评价。第 2 部分。
Bioorg Med Chem. 2013 Jun 1;21(11):2886-94. doi: 10.1016/j.bmc.2013.03.070. Epub 2013 Apr 6.
5
Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.设计、合成及咪唑啉衍生物作为 p53-MDM2 结合抑制剂的生物评价。
Bioorg Med Chem. 2011 Sep 15;19(18):5454-61. doi: 10.1016/j.bmc.2011.07.050. Epub 2011 Jul 30.
6
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity.新型1,4-苯二氮䓬-2,5-二酮作为具有改善细胞活性的Hdm2拮抗剂。
Bioorg Med Chem Lett. 2006 Jul 1;16(13):3463-8. doi: 10.1016/j.bmcl.2006.04.009. Epub 2006 May 2.
7
Design, synthesis and biological evaluation of sulfamide and triazole benzodiazepines as novel p53-MDM2 inhibitors.作为新型p53-MDM2抑制剂的磺酰胺和三唑苯二氮䓬类化合物的设计、合成及生物学评价
Int J Mol Sci. 2014 Sep 5;15(9):15741-53. doi: 10.3390/ijms150915741.
8
Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction.发现、合成和生物评价具有口服活性的吡咯烷酮衍生物作为新型 p53-MDM2 蛋白-蛋白相互作用抑制剂。
J Med Chem. 2012 Nov 26;55(22):9630-42. doi: 10.1021/jm300969t. Epub 2012 Oct 19.
9
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design.通过基于结构的药物设计增强HDM2-p53蛋白-蛋白相互作用的1,4-苯二氮䓬-2,5-二酮拮抗剂的药代动力学特性。
Bioorg Med Chem Lett. 2006 Jun 15;16(12):3310-4. doi: 10.1016/j.bmcl.2006.03.055. Epub 2006 Apr 4.
10
Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.通过药效团和基于结构的虚拟筛选鉴定Mdm2-p53相互作用的新型抑制剂。
Drug Des Devel Ther. 2018 Nov 2;12:3741-3752. doi: 10.2147/DDDT.S182444. eCollection 2018.

引用本文的文献

1
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future.MDM2 抑制剂在癌症治疗中的应用:过去、现在与未来。
Pharmacol Rev. 2024 May 2;76(3):414-453. doi: 10.1124/pharmrev.123.001026.
2
Stefano Marcaccini: a pioneer in isocyanide chemistry.斯特凡诺·马尔卡奇尼:异腈化学的先驱。
Mol Divers. 2024 Feb;28(1):335-418. doi: 10.1007/s11030-023-10641-7. Epub 2023 Apr 12.
3
Structure-Activity Relationship (SAR) Study of Spautin-1 to Entail the Discovery of Novel NEK4 Inhibitors.结构-活性关系(SAR)研究表明,Spautin-1 是一种新型 NEK4 抑制剂。
Int J Mol Sci. 2021 Jan 10;22(2):635. doi: 10.3390/ijms22020635.
4
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives.用于癌症治疗的小分子MDM2/X抑制剂和PROTAC降解剂:进展与展望
Acta Pharm Sin B. 2020 Jul;10(7):1253-1278. doi: 10.1016/j.apsb.2020.01.003. Epub 2020 Jan 14.
5
Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating Protein Expression.芳香酰胺取代苯并咪唑衍生查尔酮的设计、合成及生物评价。上调蛋白表达的作用。
Molecules. 2020 Mar 5;25(5):1162. doi: 10.3390/molecules25051162.
6
Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.G 蛋白信号调节蛋白(RGS)作为药物靶点:进展与未来潜力。
J Biol Chem. 2019 Dec 6;294(49):18571-18585. doi: 10.1074/jbc.REV119.007060. Epub 2019 Oct 21.
7
Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.新型人多形性未分化肉瘤TP53缺失细胞系mfh-val2的特性分析
Cytotechnology. 2017 Aug;69(4):539-550. doi: 10.1007/s10616-017-0112-5. Epub 2017 Jul 4.
8
The role of p53 in cancer drug resistance and targeted chemotherapy.p53在癌症耐药性和靶向化疗中的作用。
Oncotarget. 2017 Jan 31;8(5):8921-8946. doi: 10.18632/oncotarget.13475.
9
Chemical Variations on the p53 Reactivation Theme.p53 再激活主题上的化学变化
Pharmaceuticals (Basel). 2016 May 13;9(2):25. doi: 10.3390/ph9020025.
10
Design, synthesis and biological evaluation of sulfamide and triazole benzodiazepines as novel p53-MDM2 inhibitors.作为新型p53-MDM2抑制剂的磺酰胺和三唑苯二氮䓬类化合物的设计、合成及生物学评价
Int J Mol Sci. 2014 Sep 5;15(9):15741-53. doi: 10.3390/ijms150915741.